<?xml version='1.0' encoding='utf-8'?>
<document id="20578979"><sentence text="Inhibitory effects of phthalimide derivatives on the activity of the hepatic cytochrome P450 monooxygenases CYP2C9 and CYP2C19."><entity charOffset="22-33" id="DDI-PubMed.20578979.s1.e0" text="phthalimide" /></sentence><sentence text="Affecting hepatic cytochrome (CYP) activity is one of the major concerns in drug-drug interaction" /><sentence text=" Thus the testing of drug candidates on their impact on these enzymes is an essential step in early drug discovery" /><sentence text=" We tested a collection of 480 in-house phthalimide derivatives against different CYP450s using a high throughput inhibition assay"><entity charOffset="40-51" id="DDI-PubMed.20578979.s4.e0" text="phthalimide" /></sentence><sentence text=" In initial tests with the isoform CYP2C19 about 57" /><sentence text="5% of the tested phthalimide derivatives showed significantly enhanced inhibitory effects against this enzyme"><entity charOffset="17-28" id="DDI-PubMed.20578979.s6.e0" text="phthalimide" /></sentence><sentence text=" In addition similar patterns of phthalimide inhibition for CYP2C9 and CYP2C19 were found, whereas the unrelated isoforms CYP2D6 and CYP3A4 were not specifically affected"><entity charOffset="33-44" id="DDI-PubMed.20578979.s7.e0" text="phthalimide" /></sentence><sentence text=" Also less than 10% of randomly chosen substances inhibited CYP2C9" /><sentence text=" Analyses of structure-function relationships revealed that the substituent at the nitrogen atom in the isoindole ring is of crucial impact for the activity of CYP2C9/19"><entity charOffset="83-91" id="DDI-PubMed.20578979.s9.e0" text="nitrogen" /><entity charOffset="104-113" id="DDI-PubMed.20578979.s9.e1" text="isoindole" /><pair ddi="false" e1="DDI-PubMed.20578979.s9.e0" e2="DDI-PubMed.20578979.s9.e0" /><pair ddi="false" e1="DDI-PubMed.20578979.s9.e0" e2="DDI-PubMed.20578979.s9.e1" /></sentence><sentence text="" /></document>